Cardiovascular Outcomes of Patients With Non-Hodgkin Lymphoma Receiving First-Line Anthracycline-Based Immunochemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular outcomes of patients treated for non-Hodgkin lymphoma with first-line doxorubicin-based chemotherapy
Leukemia and Lymphoma 2022 Sep 18;[EPub Ahead of Print], A Zduniak, E Lévêque, A Perdrix, P Etancelin, AL Ménard, P Lenain, N Contentin, LF Pépin, S Leprêtre, E Lemasle, H Lanic, A Stamatoullas-Bastard, L Kammoun-Quique, H Tilly, F Bauer, F Jardin, V CamusFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.